Funded Tech Companies
Novadip Biosciences
Wondering who invested in Novadip Biosciences? SRIW, Vives Louvain Technology Fund and CR-CP Life Science Fund put venture money into this biopharmaceutical company.
Company Overview
Company Name
Novadip Biosciences
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Watson & Crick Hill, Rue Granbonpré 11,
Mont-Saint-Guibert, 1435
Belgium
Mont-Saint-Guibert, 1435
Belgium
Phone
Website
Email Address
Company Background Information
Overview
Novadip is transforming the lives of patients using its unique "3M3" tissue regeneration technology platform. Based on the scientific discoveries of Prof. Dr. Denis Dufrane, Novadip is a spin-off company from Université Catholique de Louvain (UCLouvain) and St. Luc University Hospital. The creation of Novadip was supported by the Louvain Technology Transfer Office (LTTO), Sopartec and VIVES II. Using our unique 3M3 tissue regeneration platform, which utilizes adipose-derived stem cells within a 3-dimensional extracellular matrix, to drive multiple product classes, Novadip's mission is to provide innovative solutions for patients with limited or no effective treatment options.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/3/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Eric Paques
Chief Executive Officer
Denis Dufrane
Chief Financial Officer
Virginie Cartage
Chief Technical Officer
Nicolas Theys
Company Investors
- SRIW
- Vives Louvain Technology Fund
- CR-CP Life Science Fund
- New Science Ventures
- InvestSud
- Private Investors (Olivier Rest)
- Private Investors (Pierre Drion)
Browse more funded tech companies:
NovaDigm Therapeutics | Novaerus
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs